Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

November 21, 2024 | John Murphy | Leave a Comment

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Authors: Bruce K. Patterson, 1 , * Edgar B. Francisco, 1 Ram Yogendra, 2 et. al., Front Immunol. 2021; 12: 746021.Published online 2022 Jan 10. doi: 10.3389/fimmu.2021. 746021PMCID: PMC8784688PMID: 35082777 Abstract The recent COVID-19 pandemic is a treatment challenge in the acute…[...]

November 16, 2024 | John Murphy | Leave a Comment

Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly

Authored by Marina Zhang via The Epoch Times Research led by scientists at Emory University in Atlanta found that while tetanus and influenza vaccines prompt the body to produce long-lived…[...]

November 13, 2024 | John Murphy | Leave a Comment

Had COVID? You’ll probably make antibodies for a lifetime

People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Authors: Ewen Callaway…[...]

October 19, 2024 | John Murphy | Leave a Comment

Did CDC Officials Mislead The Public About COVID Vaccine Efficacy? Rep. Massie Says “Yes”

Via American Greatness, When Congressman Thomas Massie (R-KY) contacted officials from the Centers for Disease Control and Prevention (CDC) in December of 2020, he wanted to know if taking the…[...]

October 16, 2024 | John Murphy | Leave a Comment

Role of MicroRNA-21 in Regulating Intracellular Pathways Associated With Phagocytosis in Human Macrophages: An In Vitro Study

Natsuki Anada • Yoshinobu Nakayama • Jun Takeshita • Kyoko Kageyama • Hiroatsu Sakamoto • Takahiko Kamibayashi • Yasufumi Nakajima 2024, DOI: 10.7759/cureus.63736 Abstract Introduction The efficient clearance of bacteria by macrophages is crucial for the timely resolution of inflammation. In this study,…[...]

October 14, 2024 | John Murphy | Leave a Comment

Spatial transcriptomics unveils the in situ cellular and molecular hallmarks of the lung in fatal COVID-19

Carlos Garcia-Prieto, Eva Musulen, Veronica Davalos, et. al.doi: https://doi.org/10.1101/2024.07.03.601404 00010010 Abstract Severe Coronavirus disease 2019 (COVID-19) induces heterogeneous and progressive diffuse alveolar damage (DAD) highly disrupting lung tissue architecture and homeostasis, hampering disease management and leading to…[...]

October 12, 2024 | John Murphy | Leave a Comment

‘Visionary’ study finds inflammation, evidence of Covid virus years after infection

By Isabella Cueto, 2024 Stat Reporting Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco. He recalls…[...]

October 9, 2024 | John Murphy | Leave a Comment

Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19

Authors: Anna Cervantes-Arslanian MD,K. H. Vincent Lau MD,Pria Anand MD, et. al. Annals of Neurology Volume 88, Issue 2 p. 211-214 Introduction In response to the coronavirus disease 2019 (COVID-19) pandemic,…[...]

October 4, 2024 | John Murphy | Leave a Comment

Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series

Authors: Christian Baumeier 1, Ganna Aleshcheva 1, Dominik Harms 1, et. al. Int J Mol Sci 2022 Jun 22;23(13):6940. doi: 10.3390/ijms23136940. Abstract Myocarditis in response to COVID-19 vaccination has been reported since early 2021. In particular, young…[...]

September 26, 2024 | John Murphy | Leave a Comment

Mini-Strokes, Gut Problems: Scientists See Links to an Old Bout of Covid

Feeling ill? The cause might be years old By Sumathi Reddy July 2, 2024 5:30 am WSJ Scientists suspect that one culprit behind your new illness might be the infection you…[...]